Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SPY vs MRNA✓SelectedUSD · MRNASPY vs MRNA performance historyLatest closeAs of-3.64%11/20
Stock and ETF performance explorer

SPY vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+195.0%
MRNA return
+786.4%
Excess return
-591.4%
Maximum drawdown
-33.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.6%-2.2%-1.5%-3.6%
7D-8.6%-12.7%+4.1%-8.1%
30D-10.8%-20.7%+9.9%-10.2%
3M-9.3%+46.3%-55.6%-10.7%
6M-6.5%+305.2%-311.7%-14.3%
YTD+1.9%+561.2%-559.3%-9.6%
1Y+6.9%+772.1%-765.2%-6.9%
3Y+57.5%+147.0%-89.5%+43.7%
5Y+57.3%-26.1%+83.4%+48.0%
All+195.0%+786.4%-591.4%+154.9%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling